gvtcx

UKHSA Diagnostics & Research Open Framework

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£6,250,000,000 (£7,500,000,000 inc. VAT)
Statuscomplete
Procedureopen
OCIDocds-h6vhtk-05d7ab

Awards (141)

This procurement was awarded to 93 suppliers. Values shown are per-award; the notice total is £6,250,000,000.

SupplierValueDateStatus
20/30 Labs shared £5,200,000,000 2 Sept 2026 pending
20/30 Labs shared £1,050,000,000 2 Sept 2026 pending
2BScientific Limited shared £5,200,000,000 2 Sept 2026 pending
2BScientific Limited shared £1,050,000,000 2 Sept 2026 pending
Abbott Laboratories Limited shared £5,200,000,000 2 Sept 2026 pending
Abbott Rapid Diagnostics Limited shared £5,200,000,000 2 Sept 2026 pending
AB Scientific Limited shared £5,200,000,000 2 Sept 2026 pending
Agena Bioscience GmbH shared £5,200,000,000 2 Sept 2026 pending
Agena Bioscience GmbH shared £1,050,000,000 2 Sept 2026 pending
Agilent Technologies LDA UK Ltd shared £5,200,000,000 2 Sept 2026 pending
Alpha Laboratories Ltd shared £5,200,000,000 2 Sept 2026 pending
Alpha Laboratories Ltd shared £1,050,000,000 2 Sept 2026 pending
Altona Diagnostics UK Ltd. shared £5,200,000,000 2 Sept 2026 pending
A.Menarini Diagnostics Ltd shared £5,200,000,000 2 Sept 2026 pending
ARGENTA INNOVATIVE LABS LTD shared £5,200,000,000 2 Sept 2026 pending
Aspect Scientific Ltd. shared £5,200,000,000 2 Sept 2026 pending
Aspect Scientific Ltd. shared £1,050,000,000 2 Sept 2026 pending
BECKMAN COULTER UNITED KINGDOM LIMITED shared £5,200,000,000 2 Sept 2026 pending
BECKMAN COULTER UNITED KINGDOM LIMITED shared £1,050,000,000 2 Sept 2026 pending
Becton, Dickinson U.K. Limited shared £5,200,000,000 2 Sept 2026 pending
Becton, Dickinson U.K. Limited shared £1,050,000,000 2 Sept 2026 pending
Be Scientific Limited shared £1,050,000,000 2 Sept 2026 pending
BioConnections Ltd shared £5,200,000,000 2 Sept 2026 pending
BIO - DIAGNOSTICS LIMITED shared £5,200,000,000 2 Sept 2026 pending
BIO - DIAGNOSTICS LIMITED shared £1,050,000,000 2 Sept 2026 pending
BioGene Limited shared £1,050,000,000 2 Sept 2026 pending
Biomerieux UK Limited shared £5,200,000,000 2 Sept 2026 pending
Bio Molecular Systems Ltd shared £1,050,000,000 2 Sept 2026 pending
Bio-Rad Laboratories Limited shared £5,200,000,000 2 Sept 2026 pending
Bio-Rad Laboratories Limited shared £1,050,000,000 2 Sept 2026 pending
Bruker UK Limited shared £5,200,000,000 2 Sept 2026 pending
Bruker UK Limited shared £1,050,000,000 2 Sept 2026 pending
Cambridge Bioscience shared £5,200,000,000 2 Sept 2026 pending
Cambridge Bioscience shared £1,050,000,000 2 Sept 2026 pending
Camlab Limited shared £5,200,000,000 2 Sept 2026 pending
Cepheid shared £5,200,000,000 2 Sept 2026 pending
Cerescom Limited shared £5,200,000,000 2 Sept 2026 pending
Cerescom Limited shared £1,050,000,000 2 Sept 2026 pending
Chirus Limited shared £5,200,000,000 2 Sept 2026 pending
Connect2pharma Ltd shared £5,200,000,000 2 Sept 2026 pending
Contained Air Solutions shared £5,200,000,000 2 Sept 2026 pending
Contained Air Solutions shared £1,050,000,000 2 Sept 2026 pending
CROWTHORNE HI-TEC SERVICES LIMITED shared £5,200,000,000 2 Sept 2026 pending
Diagnostics for the Real World Europe Limited shared £5,200,000,000 2 Sept 2026 pending
DiaSorin Ltd shared £5,200,000,000 2 Sept 2026 pending
Don Whitley Scientific Ltd shared £5,200,000,000 2 Sept 2026 pending
Don Whitley Scientific Ltd shared £1,050,000,000 2 Sept 2026 pending
ELITech UK LTD shared £5,200,000,000 2 Sept 2026 pending
Enigma Healthcare shared £5,200,000,000 2 Sept 2026 pending
Enigma Healthcare shared £1,050,000,000 2 Sept 2026 pending
E&O Laboratories Ltd shared £5,200,000,000 2 Sept 2026 pending
Eurobio Scientific UK Ltd shared £5,200,000,000 2 Sept 2026 pending
EUROFINS GENOMICS UK LIMITED shared £1,050,000,000 2 Sept 2026 pending
EUROIMMUN UK Ltd shared £5,200,000,000 2 Sept 2026 pending
EUROIMMUN UK Ltd shared £1,050,000,000 2 Sept 2026 pending
Fisher Scientific UK LTD shared £1,050,000,000 2 Sept 2026 pending
Greiner Bio-One Ltd shared £5,200,000,000 2 Sept 2026 pending
Greiner Bio-One Ltd shared £1,050,000,000 2 Sept 2026 pending
Grifols UK Ltd. shared £5,200,000,000 2 Sept 2026 pending
Hologic LTD shared £5,200,000,000 2 Sept 2026 pending
Hologic LTD shared £1,050,000,000 2 Sept 2026 pending
Home Health UK Ltd shared £5,200,000,000 2 Sept 2026 pending
Hygeia Digital Healthcare Limited shared £5,200,000,000 2 Sept 2026 pending
IDT shared £1,050,000,000 2 Sept 2026 pending
Illumina Cambridge Ltd shared £5,200,000,000 2 Sept 2026 pending
Illumina Cambridge Ltd shared £1,050,000,000 2 Sept 2026 pending
Kore Technology shared £5,200,000,000 2 Sept 2026 pending
Kore Technology shared £1,050,000,000 2 Sept 2026 pending
Launch Diagnostics Ltd shared £5,200,000,000 2 Sept 2026 pending
Launch Diagnostics Ltd shared £1,050,000,000 2 Sept 2026 pending
Life Technologies Limited shared £5,200,000,000 2 Sept 2026 pending
Life Technologies Limited shared £1,050,000,000 2 Sept 2026 pending
Mast Group Ltd shared £5,200,000,000 2 Sept 2026 pending
Mast Group Ltd shared £1,050,000,000 2 Sept 2026 pending
Medical Wire & Equipment Co (Bath) Ltd shared £5,200,000,000 2 Sept 2026 pending
Medical Wire & Equipment Co (Bath) Ltd shared £1,050,000,000 2 Sept 2026 pending
MedScience previously known as Pharmed UK shared £5,200,000,000 2 Sept 2026 pending
MedScience previously known as Pharmed UK shared £1,050,000,000 2 Sept 2026 pending
Mettler Toledo Ltd shared £5,200,000,000 2 Sept 2026 pending
Mettler Toledo Ltd shared £1,050,000,000 2 Sept 2026 pending
Microbial Genomics Ltd (Trading as MicrobesNG) shared £5,200,000,000 2 Sept 2026 pending
Microbial Genomics Ltd (Trading as MicrobesNG) shared £1,050,000,000 2 Sept 2026 pending
New England Biolabs (UK) Ltd shared £1,050,000,000 2 Sept 2026 pending
North England Laboratory Supplies shared £5,200,000,000 2 Sept 2026 pending
North England Laboratory Supplies shared £1,050,000,000 2 Sept 2026 pending
Ortho Clinical Diagnostics shared £5,200,000,000 2 Sept 2026 pending
Oxford Biosystems Ltd shared £5,200,000,000 2 Sept 2026 pending
Oxford Biosystems Ltd shared £1,050,000,000 2 Sept 2026 pending
Oxford Nanopore Technologies Ltd shared £1,050,000,000 2 Sept 2026 pending
PCR Biosystems Ltd shared £1,050,000,000 2 Sept 2026 pending
Preventx Limited shared £5,200,000,000 2 Sept 2026 pending
Pro-Lab Diagnostics shared £5,200,000,000 2 Sept 2026 pending
Pro-Lab Diagnostics shared £1,050,000,000 2 Sept 2026 pending
Promega UK Ltd shared £5,200,000,000 2 Sept 2026 pending
Promega UK Ltd shared £1,050,000,000 2 Sept 2026 pending
QCMD shared £1,050,000,000 2 Sept 2026 pending
QIAGEN LTD shared £5,200,000,000 2 Sept 2026 pending
QIAGEN LTD shared £1,050,000,000 2 Sept 2026 pending
Queen Mary University of London shared £1,050,000,000 2 Sept 2026 pending
R-Biopharm Rhone Ltd shared £5,200,000,000 2 Sept 2026 pending
REAL Digital International Ltd shared £5,200,000,000 2 Sept 2026 pending
REAL Digital International Ltd shared £1,050,000,000 2 Sept 2026 pending
Revvity (UK) Limited shared £5,200,000,000 2 Sept 2026 pending
Revvity (UK) Limited shared £1,050,000,000 2 Sept 2026 pending
Roche Diagnostics Limited shared £5,200,000,000 2 Sept 2026 pending
Sarstedt Ltd shared £5,200,000,000 2 Sept 2026 pending
Sarstedt Ltd shared £1,050,000,000 2 Sept 2026 pending
Scientific Laboratory Supplies Ltd shared £5,200,000,000 2 Sept 2026 pending
Scientific Laboratory Supplies Ltd shared £1,050,000,000 2 Sept 2026 pending
Sebia UK shared £5,200,000,000 2 Sept 2026 pending
Serosep UK shared £5,200,000,000 2 Sept 2026 pending
Shimadzu UK Ltd shared £5,200,000,000 2 Sept 2026 pending
Siemens Healthcare Diagnostics Limited shared £5,200,000,000 2 Sept 2026 pending
Source Bio International Ltd shared £5,200,000,000 2 Sept 2026 pending
Source Bio International Ltd shared £1,050,000,000 2 Sept 2026 pending
SpeeDx Ltd shared £5,200,000,000 2 Sept 2026 pending
SpeeDx Ltd shared £1,050,000,000 2 Sept 2026 pending
SPTLabtech shared £1,050,000,000 2 Sept 2026 pending
Sterilab Services shared £5,200,000,000 2 Sept 2026 pending
Sterilab Services shared £1,050,000,000 2 Sept 2026 pending
SureScreen Diagnostics Ltd shared £5,200,000,000 2 Sept 2026 pending
SureScreen Diagnostics Ltd shared £1,050,000,000 2 Sept 2026 pending
Sussex Biologicals Limited shared £5,200,000,000 2 Sept 2026 pending
Sysmex UK Ltd shared £5,200,000,000 2 Sept 2026 pending
Takara Bio Europe SAS shared £5,200,000,000 2 Sept 2026 pending
Takara Bio Europe SAS shared £1,050,000,000 2 Sept 2026 pending
Tanner Pharma shared £5,200,000,000 2 Sept 2026 pending
Tanner Pharma shared £1,050,000,000 2 Sept 2026 pending
Tecan UK shared £5,200,000,000 2 Sept 2026 pending
Tecan UK shared £1,050,000,000 2 Sept 2026 pending
Technopath Distribution shared £5,200,000,000 2 Sept 2026 pending
Technopath Distribution shared £1,050,000,000 2 Sept 2026 pending
The Binding Site Group Limited shared £5,200,000,000 2 Sept 2026 pending
Thermo Fisher Diagnostics Ltd shared £5,200,000,000 2 Sept 2026 pending
Thermo Fisher Diagnostics Ltd shared £1,050,000,000 2 Sept 2026 pending
Una Health Ltd shared £5,200,000,000 2 Sept 2026 pending
Una Health Ltd shared £1,050,000,000 2 Sept 2026 pending
VH Bio Ltd shared £5,200,000,000 2 Sept 2026 pending
VH Bio Ltd shared £1,050,000,000 2 Sept 2026 pending
VWR International Ltd shared £5,200,000,000 2 Sept 2026 pending
VWR International Ltd shared £1,050,000,000 2 Sept 2026 pending

description

UKHSA Diagnostics & Research Open Framework (DRF)

This is a competitive tendering procedure pursuant to the Notices published on the Find a Tender Central Digital Platform. UK02 Preliminary Market Engagement October 25 2025/S 000-069968, PIN Dec 24 2024/S 000-040856 and UK04 Contract Notice March 26 Notice ID: 2026/S 000-022624.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
31 Oct 2025 Preliminary market engagement (UK2) Procurement Act 2023 069968-2025
12 Mar 2026 Tender notice (UK4) Procurement Act 2023 022624-2026

more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.